Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Aquestive Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- 0 vs. Q2 2022
- Shares held
- 15.9M
- −746.0K (−4.5%) vs. Q2 2022
- Total value
- $18.6M
- +$7.88M (+73.7%) vs. Q2 2022
- New holders
- 6
- 11 more added
- Sold out
- 6
- 14 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AQST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $299.5M |
| Q1 2026 | 180 | $298.6M |
| Q4 2025 | 179 | $467.0M |
| Q3 2025 | 152 | $369.3M |
| Q2 2025 | 117 | $157.6M |
| Q1 2025 | 121 | $127.8M |
| Q4 2024 | 114 | $154.4M |
| Q3 2024 | 117 | $232.4M |
| Q2 2024 | 98 | $110.7M |
| Q1 2024 | 97 | $176.8M |
| Q4 2023 | 57 | $48.1M |
| Q3 2023 | 48 | $21.5M |
| Q2 2023 | 54 | $31.5M |
| Q1 2023 | 35 | $17.0M |
| Q4 2022 | 37 | $13.5M |
| Q3 2022 | 46 | $18.6M |
| Q2 2022 | 46 | $10.7M |
| Q1 2022 | 51 | $40.6M |
| Q4 2021 | 52 | $62.9M |
| Q3 2021 | 46 | $64.4M |
| Q2 2021 | 60 | $62.0M |
| Q1 2021 | 64 | $86.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aquestive Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 584 | $0 | 0.00% | −128−18.0% | Reduced |
| Citigroup Inc | 410 | $0 | 0.00% | −181−30.6% | Reduced |
| Strategic Asset Management, LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 1,000 | $1.00K | 0.00% | −1,000−50.0% | Reduced |
| TCI Wealth Advisors, Inc. | 500 | $1.00K | 0.00% | +200+66.7% | Added |
| China Universal Asset Management Co., Ltd. | 499 | $1.00K | 0.00% | +499 | New |
| Advisor Group Holdings, Inc. | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 3,166 | $3.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,447 | $3.00K | 0.00% | +716+41.4% | Added |
| Quantbot Technologies LP | 3,751 | $4.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 9,068 | $11.0K | 0.00% | +8,653+2,085.1% | Added |
| Running Point Capital Advisors, LLC | 10,000 | $12.0K | 0.01% | 00.0% | Unchanged |
| Bayesian Capital Management, LP | 10,235 | $12.0K | 0.00% | +10,235 | New |
| D.B. Root & Company, LLC | 12,500 | $14.0K | 0.01% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 13,704 | $16.0K | 0.00% | +13,704 | New |
| Bank of New York Mellon Corp | 14,853 | $17.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 18,063 | $21.0K | 0.00% | −53,932−74.9% | Reduced |
| Bank of Montreal | 17,730 | $21.0K | 0.00% | +531+3.1% | Added |
| Royal Bank of Canada | 20,087 | $23.0K | 0.00% | +20,087 | New |
| Mackenzie Financial Corp | 20,318 | $24.0K | 0.00% | −41,381−67.1% | Reduced |
| Wells Fargo & Company | 21,366 | $25.0K | 0.00% | −928−4.2% | Reduced |
| Susquehanna International Group, LLP | 23,850 | $28.0K | 0.00% | +23,850 | New |
| Cresset Asset Management, LLC | 26,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Financial Advocates Investment Management | 27,000 | $32.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 27,704 | $32.0K | 0.00% | +13,545+95.7% | Added |
| Group One Trading, L.P. | 29,942 | $35.0K | 0.00% | −14,357−32.4% | Reduced |
| Morgan Stanley | 33,381 | $39.0K | 0.00% | +13,517+68.0% | Added |
| Tower Research Capital LLC (TRC) | 34,875 | $41.0K | 0.00% | −3,264−8.6% | Reduced |
| Two Sigma Advisers, LP | 39,900 | $47.0K | 0.00% | −8,000−16.7% | Reduced |
| Beacon Pointe Advisors, LLC | 60,000 | $70.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 62,090 | $73.0K | 0.00% | +14,541+30.6% | Added |
| Man Group plc | 89,900 | $105.0K | 0.00% | – | – |
| State Street Corp | 96,037 | $112.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 130,305 | $152.0K | 0.00% | +130,305 | New |
| Bridgeway Capital Management, LLC | 142,956 | $167.0K | 0.00% | −61,400−30.0% | Reduced |
| Latash Investments, LLC | 243,134 | $284.0K | 0.23% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 365,899 | $428.0K | 0.00% | +121,537+49.7% | Added |
| BlackRock Inc. | 373,878 | $437.0K | 0.00% | +2,162+0.6% | Added |
| Schonfeld Strategic Advisors LLC | 406,700 | $475.0K | 0.00% | +325,600+401.5% | Added |
| Bracebridge Capital, LLC | 428,571 | $501.0K | 0.18% | 00.0% | Unchanged |
| Millennium Management LLC | 475,871 | $557.0K | 0.00% | −632,893−57.1% | Reduced |
| Vahanian & Associates Financial Planning Inc. | 695,258 | $813.0K | 2.80% | +138,500+24.9% | Added |
| Renaissance Technologies LLC | 900,800 | $1.05M | 0.00% | −325,600−26.5% | Reduced |
| Vanguard Group Inc | 1,181,540 | $1.38M | 0.00% | −100,966−7.9% | Reduced |
| Bratton Capital Management, L.P. | 9,810,958 | $11.5M | 100.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 6,500 | – | – | −500−7.1% | Reduced |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −164,607−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −124,590−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −106,408−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,261−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −14,531−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1,136−100.0% | Sold out |